2016 Hematological Malignancies
Anti-PD1 moabs and RT Synergism in preclinical models
CT26 colorektal cancer-bearing mice received 10Gy RT in 5 daily fractions of 2Gy alone or in combination with either aPD-1 (C) or aPD-L1 (D)
Made with FlippingBook
Anti-PD1 moabs and RT Synergism in preclinical models
CT26 colorektal cancer-bearing mice received 10Gy RT in 5 daily fractions of 2Gy alone or in combination with either aPD-1 (C) or aPD-L1 (D)
Made with FlippingBook